Development of clinical trial of E1A gene therapy targeting HER-2/neu-overexpressing breast and ovarian cancer

Adv Exp Med Biol. 2000;465:171-80. doi: 10.1007/0-306-46817-4_16.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase I
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Adenovirus E1A Proteins / genetics*
  • Adenovirus E1A Proteins / metabolism
  • Adenoviruses, Human / genetics*
  • Adenoviruses, Human / metabolism
  • Animals
  • Breast Neoplasms / therapy*
  • Clinical Trials as Topic
  • Female
  • Gene Expression Regulation, Neoplastic*
  • Genes, Tumor Suppressor*
  • Genetic Therapy / methods*
  • Humans
  • Ovarian Neoplasms / therapy*
  • Receptor, ErbB-2 / genetics*

Substances

  • Adenovirus E1A Proteins
  • Receptor, ErbB-2